NCT01698697View on ClinicalTrials.gov

Comparison of Two Insulin Aspart Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 2, 2002

Primary Completion Date

October 18, 2002

Study Completion Date

October 18, 2002

Conditions
DiabetesHealthy
Interventions
DRUG

insulin aspart

Bolus 0.1 U/kg administered simultaneously with a continuous infusion of 0.029 U/kg/h via a programmed insulin pump. A total dose of 0.35 U/kg is delivered to the subject in the 12 hour infusion

Trial Locations (1)

9324

Novo Nordisk Investigational Site, Bloemfontein

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY